openPR Logo
Press release

Bioengineered Protein Drugs Market to Grow 1.4X by 2025

05-05-2021 05:50 AM CET | Health & Medicine

Press release from: Fact.MR

The research study encompasses the nitty-gritty of the global Bioengineered Protein Drugs market, from future prospects to the competitive scenario, comprehensively. With DROT analysis and Porter’s Five Forces analysis, the authors have presented a platter of factors influencing the growth of global Bioengineered Protein Drugs market. Further, the global Bioengineered Protein Drugs market has been broken down into various segments, regions, end-uses and players to provide a clear picture of the present market situation to the readers.

Click HERE to Get Synopsis of the Report- https://www.factmr.com/report/4440/bioengineered-protein-drugs-market

A subject matter expert at Fact.MR opines, “The healthcare industry is experiencing a shift from curative care towards preventive care, which is projected to create more sales prospects for bioengineered protein vaccines over therapeutic proteins.”

Reports at discounted rates for new entrants!!! Purchase ASAP before the offer ends!!!

Pharmaceutical and biotechnological companies are the leading end users in the bioengineered protein drugs market, as these companies constantly strive to increase the exclusivity to their portfolios. Collectively, these end users are projected to account for 53% of the market share by 2025. However, a shift from in-house R&D towards outsourced services is augmenting the importance of contract research organisations as end users in the bioengineered protein drugs market.

Increasing reliance on these organisations for drug discovery portends the growing adoption of bioengineered protein drugs to further improve their efficacy. In addition, governments of developed regions have extended financial aid to reduce the mortality rate, which is further likely to strengthen the pathway for the penetration of bioengineered protein drugs. Though the overall market movement looks prodigious, an analytical study published by Fact.MR foresees the advent of generic drugs as an impeder to the growth of the global bioengineered protein drugs market.

For detailed insights on enhancing your product footprint, request for a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=4440

Key Highlights of Bioengineered Protein Drugs Market

Patients suffering from cancer continue to remain the target audience of players in the bioengineered protein drugs market. Adoption of bioengineered protein drugs for treatment is projected to increase at a CAGR of around 7% during the forecast period (2020-2025). Also, a spurt in the sales of these drugs is expected, which is likely to be driven by individuals diagnosed with infectious diseases.

High costs associated with bioengineered protein drugs, in tandem with their short shelf life, causes reluctance among patients towards their adoption. In addition, increasing development of biosimilar products that cost just 20% of branded drugs is expected to deter revenue potential of the bioengineered protein drugs market during the forecast period.

Preference for oral route of drug administration for any medication is high among patients, on the back of convenience and ease. However, bioengineered protein drugs are difficult to administer in an oral formulation, on account of gastric acid formed in the stomach, which could impede their adoption rate.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4440

Prominent Players Rely on Generic Drugs and Strong Distribution Network

F.Hoffmann-La Roche, AbbVie, and Johnson & Johnson are the leading players, collectively accounting for around 60% share in the global bioengineered protein drugs market. The focal point of these players is on the development of branded drugs to treat myriad rare diseases. A substantial revenue of F.Hoffmann-La Roche is attributable to its blockbuster drugs - Avastin, Rituxan, and Herceptin, specifically developed for the treatment of cancer. Another leading player, AbbVie, holds a dominant position in the bioengineered protein drugs market, on account of its flagship product-Humira-which is considered as a breakthrough product to treat a number of conditions and diseases.

In contrast to the focus of leading players on the development of branded drugs, prominent and emerging players strive to ace the market race through generic formulations. Also, they take measured actions towards strengthening their distribution network to increase the accessibility of their products.

For in-depth competitive analysis, buy now- https://www.factmr.com/checkout/4440/S

Find More Valuable Insights on Bioengineered Protein Drugs Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global bioengineered protein drugs market, presenting historical demand data (2015-2019), and forecast statistics for the period of 2020-2025. The study divulges compelling insights on the bioengineered protein drugs market on the basis of drug type (monoclonal antibodies, therapeutic protein, and vaccines), disease (cancer, diabetes, autoimmune disorder, infectious disease, haematopoiesis, CVD, neurodegenerative, and others), and end user (pharmaceutical and biotechnology companies, CROs, and research institutes), across five major regions.

For More Insights: https://www.biospace.com/article/product-miniaturization-and-multi-parameter-applications-drives-capnography-market-fact-mr/

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email : sales@factmr.com
Website : https://www.factmr.com
Research Insight: https://www.factmr.com/report/4440/bioengineered-protein-drugs-market
Content Source: https://www.factmr.com/media-release/1223/global-bioengineered-protein-drugs-market

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.
We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.
Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.
Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bioengineered Protein Drugs Market to Grow 1.4X by 2025 here

News-ID: 2279982 • Views: 161

More Releases from Fact.MR

Organic Sulfur Market Global Demand, Growth, Opportunities, Top Key Players and …
Fact.MR has adopted multi-disciplinary approach to shed light on the keyword during the historical period. The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year, and key prospects over the forecast period 2018-2028. The insights and analytics on the Organic Sulfur Market span several pages. These are covered in numerous sections, including, drivers and restraints, challenges and opportunities, regional segmentation and opportunity assessment,
GLA Supplements Market Key Players, SWOT Analysis, Dynamics, Drivers, Key Indica …
Fact.MR has adopted multi-disciplinary approach to shed light on the GLA Supplements during the historical period. The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year, and key prospects over the forecast period 2018-2028. The insights and analytics on the GLA Supplements Market span several pages. These are covered in numerous sections, including, drivers and restraints, challenges and opportunities, regional segmentation and opportunity
Global Electrotechnical Paper Market to Create an Absolute Dollar Opportunity of …
The recently published market study by Fact.MR highlights the current trends that are expected to influence the dynamics of the Electrotechnical Paper Market in the upcoming years. Click here to Get Complete Synopsis of the Report – https://www.factmr.com/report/1956/electrotechnical-paper-market The report introspects the supply chain, cost structure, and recent developments pertaining to the Electrotechnical Paper Market in the report and the impact of the COVID-19 on these facets of the market. Further,
Global Dibenzyl Toluene Marke to Expand 1.4X by 2030 end | Eastman Chemicals, Ar …
The recently published market study by Fact.MR highlights the current trends that are expected to influence the dynamics of the Dibenzyl Toluene Market in the upcoming years. Click here to Get Complete Synopsis of the Report - https://www.factmr.com/report/4843/dibenzyl-toluene-market   The report introspects the supply chain, cost structure, and recent developments pertaining to the Dibenzyl Toluene Market in the report and the impact of the COVID-19 on these facets of the market. Further,

All 5 Releases


More Releases for Drugs

Acne Drugs: Global Markets
The global market for acne drugs was valued at REDACTED in 2019. The market is expected to growat a compound annualgrowth rate (CAGR) of REDACTED to reach REDACTED by 2025. Growth of the global market is attributed the increasing numberof cases of acne and skin diseases, unhealthy eating habits and the rising adoption of skin care productsworldwide. To Get Sample Copy of Report Visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=2798596 Increasing prevalence of the acne and
Acne Drugs Market
According to IMARC Group’s latest report, titled “Acne Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,”. Looking forward, IMARC Group expects the global acne drugs market to continue its moderate growth during the next five years. Acne drugs are medications used to treat a dermatological infection caused by the inflammation in the hair follicles on the skin. It is generally due to hormonal imbalance, oily skin, accumulation of
Global Cardiovascular Drugs Market
Global Cardiovascular Drugs Market – Industry Analysis and Forecast (2018-2026) – by Drug Class, Indications, Distribution Channels, and Region. Global Cardiovascular Drugs Market was valued at US$ 80.5 Bn in 2017 and is expected to reach US$ 98.8 Bn by 2026, at a CAGR of 2.6 % during the forecast period. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,
Cardiovascular Drugs Market | Insights
Some of the common cardiovascular diseases include hypertensive heart disease, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease. Major problems associated with hypertensive heart disease include angina, hypertrophy, and heart failure. These problems are caused due to high blood pressure in the heart’s arteries and muscles, which causes narrowing of arteries and thickening and enlargement of heart. The global cardiovascular drug market is primarily driven
Immunotherapy Drugs Market
Immunotherapy drugs are used to treat cancer, infection, respiratory and autoimmune disorders. Immunotherapies either stimulate the activities done by specific components of the immune system or counteract the signals that are produced by the cancer cells and suppress the immune responses. The Immunotherapy Drugs Market accounted to USD 107 billion in 2016 growing at a CAGR of 13.2% during the forecast period of 2017 to 2024. The upcoming market report contains
Immunotherapy Drugs Market
Immunotherapy is the management of a disease by enhancing, suppressing, or inducing an immune response. Some immunotherapies are designed to magnify or elicit an immune response. They are known as activation immunotherapies. However, some immunotherapies that suppress or reduce the immune response are known as suppression immunotherapies. Cell-based immunotherapies are useful for some types of cancers. Immune effector cells includingmacrophages, dendritic cells, lymphocytes, cytotoxic T lymphocytes (CTL), natural killer cells